Skandinaviska Enskilda Banken Ab (Publ) Exact Sciences Corp Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

$20.3 Billion
Q1 2024

A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Exact Sciences Corp stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 369,636 shares of EXAS stock, worth $15.6 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

369,636

Previous 431,267 14.29%

Holding current value

$15.6 Million

Previous $31.9 Million 19.99%

% of portfolio

0.13%

Previous 0.19%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$56.27 - $73.77 $3.47 Million - $4.55 Million	-61,631 Reduced 14.29%	369,636 $25.5 Million
Q4 2023 Feb 14, 2024	BUY	$59.06 - $75.72 $11.7 Million - $15 Million	197,600 Added 84.56%	431,267 $31.9 Million
Q3 2023 Nov 09, 2023	BUY	$65.94 - $99.04 $13.1 Million - $19.7 Million	199,222 Added 578.38%	233,667 $15.9 Million
Q2 2023 Aug 07, 2023	BUY	$62.68 - $95.05 $194,433 - $294,845	3,102 Added 9.9%	34,445 $3.23 Million
Q1 2023 May 11, 2023	BUY	$47.19 - $70.77 $2,548 - $3,821	54 Added 0.17%	31,343 $2.13 Million

Q4 2022 Feb 08, 2023	BUY	$30.35 - $53.15 $10,865 - $19,027	358 Added 1.16%	31,289 $1.55 Million
Q3 2022 Nov 14, 2022	SELL	$31.97 - $49.37 $329,738 - $509,202	-10,314 Reduced 25.01%	30,931 $1.01 Million
Q2 2022 Aug 10, 2022	BUY	$35.61 - $76.23 $116,017 - $248,357	3,258 Added 8.58%	41,245 $1.63 Million
Q1 2022 May 11, 2022	SELL	$57.56 - $82.54 $350,195 - $502,173	-6,084 Reduced 13.8%	37,987 $2.66 Million
Q4 2021 Feb 10, 2022	SELL	$72.5 - $100.68 $4.68 Million - $6.5 Million	-64,600 Reduced 59.45%	44,071 $3.43 Million
Q3 2021 Nov 10, 2021	SELL	$90.24 - $124.05 $7.76 Million - $10.7 Million	-86,006 Reduced 44.18%	108,671 $10.4 Million
Q2 2021 Aug 10, 2021	BUY	$93.66 - $139.27 $5.78 Million - $8.59 Million	61,662 Added 46.36%	194,677 $24.2 Million
Q1 2021 May 14, 2021	BUY	$116.57 - $155.01 $10.7 Million - $14.2 Million	91,655 Added 221.6%	133,015 $17.5 Million
Q4 2020 Feb 11, 2021	BUY	$99.61 - $142.12 $316,759 - $451,941	3,180 Added 8.33%	41,360 $5.48 Million
Q3 2020 Nov 12, 2020	BUY	$72.92 - $102.01 $1.1 Million - $1.54 Million	15,112 Added 65.51%	38,180 $3.89 Million
Q2 2020 Aug 13, 2020	BUY	$55.75 - $92.75 $260,241 - $432,957	4,668 Added 25.37%	23,068 $2.01 Million
Q1 2020 May 13, 2020	SELL	$37.9 - $104.44 $795,483 - $2.19 Million	-20,989 Reduced 53.29%	18,400 $1.07 Million
Q4 2019 Feb 14, 2020	BUY	$77.66 - $99.74 $1.7 Million - $2.18 Million	21,889 Added 125.08%	39,389 $3.64 Million
Q3 2019 Nov 08, 2019	BUY	$90.37 - $122.49 $243,999 - $330,723	2,700 Added 18.24%	17,500 $1.58 Million
Q2 2019 Aug 09, 2019	BUY	$89.51 - $118.04 $1.32 Million - $1.75 Million	14,800 New	14,800 $1.75 Million

Others Institutions Holding EXAS

# of Institutions

699

Shares Held

160M

Call Options Held

5.84M

Put Options Held

2.58M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $7.48B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.

Account

Skandinaviska Enskilda Banken Ab (Publ) Exact Sciences Corp Transaction History